6 Vote!

Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials

An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers have shown....

read more...

Share |

Source: PhysOrg - Tuesday, 7 February


Related articles: